In this subdivision:

1. I. [Repealed.]
2. II. "Commissioner" means the commissioner of the department of health and human services.
3. III. "Controlled substance" means controlled drugs as defined in RSA 318-B:1, VI.
4. IV. "Department" means the department of health and human services, established in RSA 126-A:4.
5. V. "Dispense" means to deliver a controlled substance by lawful means and includes the packaging, labeling, or compounding necessary to prepare the substance for such delivery.

6. VI. "Dispenser" means a person or entity who is lawfully authorized to deliver a schedule II-IV controlled substance, but does not include:

   1. (a) A licensed hospital pharmacy under RSA 318 that dispenses less than a 48-hour supply of a schedule II-IV controlled substance from a hospital emergency department or that dispenses for administration in the hospital;
   2. (b) A practitioner, or other authorized person who administers such a substance;
   3. (c) A wholesale distributor of a schedule II-IV controlled substance or its analog;
   4. (d) A prescriber who dispenses less than a 48-hour supply of a schedule II-IV controlled substance from a hospital emergency department to a patient;
   5. (e) A veterinarian who dispenses less than a 48-hour supply of a schedule II-IV controlled substance to a patient; or

   6. (f) A practitioner who does not hold or operate under an active Drug Enforcement Agency registration number to prescribe or dispense controlled substances.

      VI-a. "Integrative pain management" means the systematic combination of a variety of allopathic and non-allopathic services that address the biological, psychological, social, and spiritual needs of the patient. It is person-centered and focuses on maximizing function and wellness. Care plans are developed through a shared decision-making model that reflects the available evidence regarding optimal clinical practice and the person's goals and values.

7. VII. "Patient" means the person or animal who is the ultimate user of a controlled substance for whom a lawful prescription is issued and for whom a controlled substance or other such drug is lawfully dispensed.
8. VIII. "Practitioner" means a physician, dentist, podiatrist, veterinarian, pharmacist, APRN, physician associate, naturopath, or other person licensed or otherwise permitted to prescribe, dispense, or administer a controlled substance in the course of licensed professional practice. "Practitioner" shall also include practitioners with a federal license to prescribe or administer a controlled substance.
9. IX. "Prescribe" means to issue a direction or authorization, by prescription, permitting a patient to lawfully obtain controlled substances.
10. X. "Prescriber" means a practitioner or other authorized person who prescribes a schedule II, III, or IV controlled substance.
11. XI. "Program" means the controlled drug prescription health and safety program that electronically facilitates the confidential sharing of information relating to the prescribing and dispensing of controlled substances listed in schedules II-IV, established by the department pursuant to RSA 126-A:90.

Source. 2021, 91:45, eff. July 1, 2021; 148:6, eff. July 1, 2021. 2023, 140:8, I, eff. Aug. 29, 2023. 2024, 126:1, eff. Sept. 1, 2024. 2025, 105:1, eff. June 17, 2025.